Table of Contents
In This Issue
Interview with Senopsys LLC's Founder & President, Mr. Jeff Worthington
Drug Reconstitution
Active & Passive Transdermal Systems
Topical Delivery
Outsourcing Formulation Development
Peptides & Antibodies
Licensing Strategies
Comparison of EUDRAGIT FS 30 D & EUDRAGIT L 30 D-55 as Matrix Formers in Sustained-Release Tablets
Transdermal Delivery: Product Development Pursues Active & Passive Systems
OraVescent® Technology Offers Greater Oral Transmucosal Delivery
SEPA®, DermaPass™ & MacroDerm™: Exciting Possibilities for Topical Delivery & Specialty Pharma
Senopsys LLC: Dedicated to the Development of Palatable Pharmaceuticals
Hypogonadism Solution Through Transdermal Androgen Replacement: Drug-In-Polymer Transdermal Delivery System
Assessing Formulation Development in Specialty Pharma
CovX: Leveraging the Best From Peptides & Antibodies
Specialty Pharma: Business Development & Licensing Strategies
Departments
Market News & Trends
Advanced Delivery Devices
Technology Showcase
Facts & Figures
External Delivery

Drug Delivery Technology - July/August 2007 Index

Drug Delivery Technology - July/August 2007 - Comparison of EUDRAGIT FS 30 D & EUDRAGIT L 30 D-55 as Matrix Formers in Sustained-Release Tablets (Page 30)

Drug Delivery Technology - July/August 2007 - Comparison of EUDRAGIT FS 30 D & EUDRAGIT L 30 D-55 as Matrix Formers in Sustained-Release Tablets (Page 31)

Drug Delivery Technology - July/August 2007 - Comparison of EUDRAGIT FS 30 D & EUDRAGIT L 30 D-55 as Matrix Formers in Sustained-Release Tablets (Page 32)

Drug Delivery Technology - July/August 2007 - Comparison of EUDRAGIT FS 30 D & EUDRAGIT L 30 D-55 as Matrix Formers in Sustained-Release Tablets (Page 33)

Drug Delivery Technology - July/August 2007 - Comparison of EUDRAGIT FS 30 D & EUDRAGIT L 30 D-55 as Matrix Formers in Sustained-Release Tablets (Page 34)

Drug Delivery Technology - July/August 2007 - Comparison of EUDRAGIT FS 30 D & EUDRAGIT L 30 D-55 as Matrix Formers in Sustained-Release Tablets (Page 35)

Drug Delivery Technology - July/August 2007 - Transdermal Delivery: Product Development Pursues Active & Passive Systems (Page 36)

Drug Delivery Technology - July/August 2007 - Transdermal Delivery: Product Development Pursues Active & Passive Systems (Page 37)

Drug Delivery Technology - July/August 2007 - Transdermal Delivery: Product Development Pursues Active & Passive Systems (Page 38)

Drug Delivery Technology - July/August 2007 - Transdermal Delivery: Product Development Pursues Active & Passive Systems (Page 39)

Drug Delivery Technology - July/August 2007 - Transdermal Delivery: Product Development Pursues Active & Passive Systems (Page 40)

Drug Delivery Technology - July/August 2007 - Transdermal Delivery: Product Development Pursues Active & Passive Systems (Page 41)

Drug Delivery Technology - July/August 2007 - OraVescent® Technology Offers Greater Oral Transmucosal Delivery (Page 42)

Drug Delivery Technology - July/August 2007 - OraVescent® Technology Offers Greater Oral Transmucosal Delivery (Page 43)

Drug Delivery Technology - July/August 2007 - OraVescent® Technology Offers Greater Oral Transmucosal Delivery (Page 44)

Drug Delivery Technology - July/August 2007 - OraVescent® Technology Offers Greater Oral Transmucosal Delivery (Page 45)

Drug Delivery Technology - July/August 2007 - SEPA®, DermaPass™ & MacroDerm™: Exciting Possibilities for Topical Delivery & Specialty Pharma (Page 46)

Drug Delivery Technology - July/August 2007 - SEPA®, DermaPass™ & MacroDerm™: Exciting Possibilities for Topical Delivery & Specialty Pharma (Page 47)

Drug Delivery Technology - July/August 2007 - SEPA®, DermaPass™ & MacroDerm™: Exciting Possibilities for Topical Delivery & Specialty Pharma (Page 48)

Drug Delivery Technology - July/August 2007 - SEPA®, DermaPass™ & MacroDerm™: Exciting Possibilities for Topical Delivery & Specialty Pharma (Page 49)

Drug Delivery Technology - July/August 2007 - SEPA®, DermaPass™ & MacroDerm™: Exciting Possibilities for Topical Delivery & Specialty Pharma (Page 50)

Drug Delivery Technology - July/August 2007 - SEPA®, DermaPass™ & MacroDerm™: Exciting Possibilities for Topical Delivery & Specialty Pharma (Page 51)

Drug Delivery Technology - July/August 2007 - Senopsys LLC: Dedicated to the Development of Palatable Pharmaceuticals (Page 52)

Drug Delivery Technology - July/August 2007 - Senopsys LLC: Dedicated to the Development of Palatable Pharmaceuticals (Page 53)

Drug Delivery Technology - July/August 2007 - Senopsys LLC: Dedicated to the Development of Palatable Pharmaceuticals (Page 54)

Drug Delivery Technology - July/August 2007 - Hypogonadism Solution Through Transdermal Androgen Replacement: Drug-In-Polymer Transdermal Delivery System (Page 55)

Drug Delivery Technology - July/August 2007 - Hypogonadism Solution Through Transdermal Androgen Replacement: Drug-In-Polymer Transdermal Delivery System (Page 56)

Drug Delivery Technology - July/August 2007 - Hypogonadism Solution Through Transdermal Androgen Replacement: Drug-In-Polymer Transdermal Delivery System (Page 57)

Drug Delivery Technology - July/August 2007 - Hypogonadism Solution Through Transdermal Androgen Replacement: Drug-In-Polymer Transdermal Delivery System (Page 58)

Drug Delivery Technology - July/August 2007 - Hypogonadism Solution Through Transdermal Androgen Replacement: Drug-In-Polymer Transdermal Delivery System (Page 59)

Drug Delivery Technology - July/August 2007 - Hypogonadism Solution Through Transdermal Androgen Replacement: Drug-In-Polymer Transdermal Delivery System (Page 60)

Drug Delivery Technology - July/August 2007 - Hypogonadism Solution Through Transdermal Androgen Replacement: Drug-In-Polymer Transdermal Delivery System (Page 61)

Drug Delivery Technology - July/August 2007 - Hypogonadism Solution Through Transdermal Androgen Replacement: Drug-In-Polymer Transdermal Delivery System (Page 62)

Drug Delivery Technology - July/August 2007 - Hypogonadism Solution Through Transdermal Androgen Replacement: Drug-In-Polymer Transdermal Delivery System (Page 63)

Drug Delivery Technology - July/August 2007 - Hypogonadism Solution Through Transdermal Androgen Replacement: Drug-In-Polymer Transdermal Delivery System (Page 64)

Drug Delivery Technology - July/August 2007 - Hypogonadism Solution Through Transdermal Androgen Replacement: Drug-In-Polymer Transdermal Delivery System (Page 65)

Drug Delivery Technology - July/August 2007 - Assessing Formulation Development in Specialty Pharma (Page 66)

Drug Delivery Technology - July/August 2007 - Assessing Formulation Development in Specialty Pharma (Page 67)

Drug Delivery Technology - July/August 2007 - Assessing Formulation Development in Specialty Pharma (Page 68)

Drug Delivery Technology - July/August 2007 - Assessing Formulation Development in Specialty Pharma (Page 69)

Drug Delivery Technology - July/August 2007 - Assessing Formulation Development in Specialty Pharma (Page 70)

Drug Delivery Technology - July/August 2007 - Assessing Formulation Development in Specialty Pharma (Page 71)

Drug Delivery Technology - July/August 2007 - CovX: Leveraging the Best From Peptides & Antibodies (Page 72)

Drug Delivery Technology - July/August 2007 - CovX: Leveraging the Best From Peptides & Antibodies (Page 73)

Drug Delivery Technology - July/August 2007 - CovX: Leveraging the Best From Peptides & Antibodies (Page 74)

Drug Delivery Technology - July/August 2007 - CovX: Leveraging the Best From Peptides & Antibodies (Page 75)

Drug Delivery Technology - July/August 2007 - Specialty Pharma: Business Development & Licensing Strategies (Page 76)

Drug Delivery Technology - July/August 2007 - Specialty Pharma: Business Development & Licensing Strategies (Page 77)

Drug Delivery Technology - July/August 2007 - Specialty Pharma: Business Development & Licensing Strategies (Page 78)

Drug Delivery Technology - July/August 2007 - Specialty Pharma: Business Development & Licensing Strategies (Page 79)

Drug Delivery Technology - July/August 2007 - Specialty Pharma: Business Development & Licensing Strategies (Page 80)

Drug Delivery Technology - July/August 2007 - Specialty Pharma: Business Development & Licensing Strategies (Page 81)

Drug Delivery Technology - July/August 2007 - Specialty Pharma: Business Development & Licensing Strategies (Page 82)

Drug Delivery Technology - July/August 2007 - Specialty Pharma: Business Development & Licensing Strategies (Page 83)

Drug Delivery Technology - July/August 2007 - Specialty Pharma: Business Development & Licensing Strategies (Page 84)

Digital edition of Drug Delivery Technology - July/August 2007 provided by Texterity, Inc.